Candida auris cases more than doubled from 2022 to 2024, CDC reports. How much of the rise in this drug-resistant fungus is ...
Albumin triggers fungal virulence: Candida albicans forms denser biofilms in the presence of human albumin (right) compared to its absence (left), revealing a hidden pathogenicity pathway. Candida ...
The yeast fungus Candida albicans not only uses the toxin candidalysin to cause infections, but also to colonize the oral mucosa inconspicuously—but only in finely balanced amounts. Too little toxin ...
Researchers at the Optics and Photonics Research Center (CePOF) have succeeded in increasing the susceptibility of the fungus Candida albicans to drug treatment through light-activated therapy. The ...
Hyphal morphogenesis is a defining trait of many pathogenic fungi, enabling a switch from unicellular yeast growth to multicellular filaments that invade host tissues. This complex process begins with ...
“In our study, we focused on Candida albicans and the importance of its toxin Candidalysin. The fungus is a natural part of the human microbiome and coexists with numerous other microorganisms such as ...
Researchers at the Optics and Photonics Research Center (CePOF) have succeeded in increasing the susceptibility of the fungus Candida albicans to drug treatment through light-activated therapy. The ...
Umeå University researchers, Sweden, unveil how the most common white blood cells, neutrophils, counter Candida albicans toxin stopping its tracks. The results have been published in EMBO Reports. We ...
WASHINGTON, DC — Research on the gut microbiome — and clinical attention to it — has focused mainly on bacteria, but bacteriophages and fungi play critical roles as well, with significant influences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results